Lactoferrin perturbs intracellular trafficking, disrupts cholesterol-rich lipid rafts and inhibits glycolysis of highly metastatic cancer cells harbouring plasmalemmal V-ATPase

• Published in: International journal of biological macromolecules Vol. 220; pp. 1589 - 1604
• Main Authors: Santos-Pereira, Cátia, Guedes, Joana P., Ferreira, Débora, Rodrigues, Lígia R., Côrte-Real, Manuela
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 01-11-2022
• Subjects: Lactoferrin; Lipid rafts; V-ATPase; Lactoferrin; Lipid rafts; V-ATPase
• ISSN: 0141-8130; 1879-0003
• DOI: 10.1016/j.ijbiomac.2022.09.120

The milk-derived bovine lactoferrin (bLf) is an iron-binding glycoprotein with remarkable selective anticancer activity towards highly metastatic cancer cells displaying the proton pump V-ATPase at the plasma membrane. As studies aiming to dissect the bLf mechanisms of action are critical to improve its efficacy and boost its targeted clinical use, herein we sought to further uncover the molecular basis of bLf anticancer activity. We showed that bLf co-localizes with V-ATPase and cholesterol-rich lipid rafts at the plasma membrane of highly metastatic cancer cells. Our data also revealed that bLf perturbs cellular trafficking, induces intracellular accumulation of cholesterol and lipid rafts disruption, downregulates PI3K, and AKT or p-AKT and inhibits glycolysis of cancer cells harbouring V-ATPase at the plasma membrane lipid rafts. Altogether, our results can lay the foundation for future bLf-based targeted anticancer strategies as they unravel a novel cascade of molecular events that explains and further reinforces bLf selectivity for cancer cells displaying plasmalemmal V-ATPase.
•Lactoferrin perturbs intracellular trafficking and inhibits glycolysis.•Lactoferrin disrupts cholesterol-rich lipid rafts of highly metastatic cancer cells.•A novel cascade of molecular events triggered by lactoferrin in cancer cells was unveiled.